Perrigo (PRGO) Change in Intangibles (2015 - 2026)
Perrigo (PRGO) posted quarterly Change in Intangibles of $1.4 million for Q1 2026, down 17.65% year-over-year from $1.7 million in Q1 2025, and down 41.67% quarter-over-quarter from $2.4 million in Q4 2025.
Perrigo (PRGO) Change in Intangibles (2015 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Change in Intangibles for 12 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Intangibles fell 17.65% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $5.3 million (changed 0.0% YoY), while the FY2025 annual figure was $5.6 million, up 7.69% from the prior year.
- Change in Intangibles declined to $1.4 million in Q1 2026 per PRGO's latest filing, from $2.4 million in the prior quarter.
- Across five years, Change in Intangibles topped out at $15.6 million in Q3 2023 and bottomed at $500000.0 in Q3 2025.
- Historically, Change in Intangibles has averaged $2.1 million across 5 years, with a median of $1.4 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Intangibles soared 2500.0% — and 2024, when it plunged 94.23%.
- Perrigo's Change in Intangibles stood at $600000.0 in 2022, then soared by 150.0% to $1.5 million in 2023, then rose by 13.33% to $1.7 million in 2024, then soared by 41.18% to $2.4 million in 2025, then sank by 41.67% to $1.4 million in 2026.
- Business Quant data shows PRGO's Change in Intangibles at $1.4 million in Q1 2026, $2.4 million in Q4 2025, and $500000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.09 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 1.40 Mn |
| Mar 28, 2026 | 1.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 27, 2025 | 500,000.00 |
| Sep 27, 2025 | 500,000.00 |
| Jun 28, 2025 | 1.00 Mn |
| Jun 28, 2025 | 1.00 Mn |
| Mar 29, 2025 | 1.70 Mn |
| Mar 29, 2025 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 28, 2024 | 1.00 Mn |
| Sep 28, 2024 | 1.00 Mn |
| Jun 29, 2024 | 900,000.00 |
| Jun 29, 2024 | 900,000.00 |
| Mar 30, 2024 | 1.60 Mn |
| Mar 30, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |